Related Experiment Videos
Molecular aspects of Gaucher disease
1Department of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
Developmental Neuroscience
|January 1, 1991
Summary
Gaucher disease, a sphingolipid storage disorder, can be misdiagnosed due to co-occurring neurological conditions. Genetic analysis reveals distinct mutations, aiding in accurate Gaucher disease diagnosis and understanding genotype-phenotype correlations.
Area of Science:
- Genetics
- Biochemistry
- Neurology
Background:
- Gaucher disease is the most prevalent sphingolipid storage disorder.
- Its prevalence can lead to misinterpretation as Gaucher type 3 when presenting with unrelated neurological conditions.
- A family case highlights diagnostic challenges with varying clinical presentations.
Purpose of the Study:
- To describe a family with Gaucher disease exhibiting diverse clinical signs.
- To identify specific genetic mutations in Gaucher disease patients.
- To investigate genotype-phenotype correlations and prosaposin gene expression.
Main Methods:
- Molecular analysis of patient DNA to identify gene mutations.
- Diagnostic testing of 161 patients for mutation profiling.
- Northern blot and in situ hybridization for prosaposin gene expression analysis.
Main Results:
- Two brothers with Gaucher disease carried different mutated alleles, confirming the same disease type despite varied symptoms.
- Molecular diagnosis of 161 patients revealed mutation frequency differences between Jewish and non-Jewish populations.
- Prosaposin gene shows high expression in brain and testes, with specific localization in supporting cells and corpus luteum; also detected in embryonic tissues.
Conclusions:
- Accurate molecular diagnosis is crucial for Gaucher disease, especially when neurological symptoms are present.
- Genotype-phenotype correlations are being established through extensive molecular diagnostics.
- Prosaposin gene expression patterns suggest its role in specific tissues and embryonic development.